[Sympathetic nervous system].
Takahashi
Hakuo
H
Department of Clinical Sciences and Laboratory Medicine, Kansai Medical University.
D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000818:Animals; D000959:Antihypertensive Agents / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000209:etiology / Q000628:therapy; D007333:Insulin Resistance; D020738:Leptin / Q000502:physiology; D008019:Life Style; D024821:Metabolic Syndrome / Q000209:etiology; D009765:Obesity / Q000209:etiology; D013564:Sympathetic Nervous System / Q000502:physiology* / Q000503:physiopathology
D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D020738:Leptin